Trial Outcomes & Findings for The TARANG Intervention (NCT NCT06320964)

NCT ID: NCT06320964

Last Updated: 2025-02-06

Results Overview

Proportion of participants who complete 50% of the intervention sessions

Recruitment status

COMPLETED

Study phase

Target enrollment

42 participants

Primary outcome timeframe

Post-intervention at 5 month endline survey

Results posted on

2025-02-06

Participant Flow

Participant milestones

Participant milestones
Measure	TARANG Arm Received 16 lifeskills and reproductive health empowerment sessions
Overall Study STARTED	42
Overall Study COMPLETED	42
Overall Study NOT COMPLETED	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

The TARANG Intervention

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	TARANG Arm n=42 Participants A single-arm trial in which intervention groups receive an introductory rapport-building session, followed by 16 group sessions facilitated by the moderators over six months. The intervention used practical skill-building activities to empower participants by enhancing their understanding of fundamental topics such as menstruation, conception, and contraception.
Age, Continuous	20.3 Years STANDARD_DEVIATION 1.6 • n=99 Participants
Sex: Female, Male Female	42 Participants n=99 Participants
Sex: Female, Male Male	0 Participants n=99 Participants
Race (NIH/OMB) American Indian or Alaska Native	0 Participants n=99 Participants
Race (NIH/OMB) Asian	42 Participants n=99 Participants
Race (NIH/OMB) Native Hawaiian or Other Pacific Islander	0 Participants n=99 Participants
Race (NIH/OMB) Black or African American	0 Participants n=99 Participants
Race (NIH/OMB) White	0 Participants n=99 Participants
Race (NIH/OMB) More than one race	0 Participants n=99 Participants
Race (NIH/OMB) Unknown or Not Reported	0 Participants n=99 Participants

PRIMARY outcome

Timeframe: Post-intervention at 5 month endline survey

Population: The outcome was only analyzed for those participants who attended at least one session.

Proportion of participants who complete 50% of the intervention sessions

Outcome measures

Outcome measures
Measure	TARANG Arm n=35 Participants A single-arm trial in which intervention groups receive an introductory rapport-building session, followed by 16 group sessions facilitated by the moderators over six months. The intervention used practical skill-building activities to empower participants by enhancing their understanding of fundamental topics such as menstruation, conception, and contraception.
Feasibility of the Intervention	28 Participants

PRIMARY outcome

Timeframe: Post-intervention at 5 month endline survey

Population: Only participants who attended at least one session were analyzed.

Proportion of participants who were completely or somewhat satisfied with the intervention

Outcome measures

Outcome measures
Measure	TARANG Arm n=35 Participants A single-arm trial in which intervention groups receive an introductory rapport-building session, followed by 16 group sessions facilitated by the moderators over six months. The intervention used practical skill-building activities to empower participants by enhancing their understanding of fundamental topics such as menstruation, conception, and contraception.
Acceptability	34 Participants

PRIMARY outcome

Timeframe: Post-intervention at 5 month endline survey

Population: Only those who attended at least one session were asked about usefulness of sessions.

Proportion of participants who found the TARANG intervention sessions very useful or somewhat useful

Outcome measures

Outcome measures
Measure	TARANG Arm n=35 Participants A single-arm trial in which intervention groups receive an introductory rapport-building session, followed by 16 group sessions facilitated by the moderators over six months. The intervention used practical skill-building activities to empower participants by enhancing their understanding of fundamental topics such as menstruation, conception, and contraception.
Usefulness	35 Participants

Adverse Events

TARANG Arm

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Nadia Diamond-Smith, PhD, MS

University of California, San Francisco

Phone: (415) 502-5800

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place